Inhibitor for protein disulfide‑isomerase family A member 3 enhances the antiproliferative effect of inhibitor for mechanistic target of rapamycin in liver cancer: An in vitro study on combination treatment with everolimus and 16F16-Reference-Cited by-同舟云学术

Inhibitor for protein disulfide‑isomerase family A member 3 enhances the antiproliferative effect of inhibitor for mechanistic target of rapamycin in liver cancer: An in vitro study on combination treatment with everolimus and 16F16

Published:2020-11-11 Issue:1 Volume:21 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Kaneya Yohei¹,Takata Hideyuki²,Wada Ryuichi¹,Kure Shoko¹,Ishino Kousuke¹,Kudo Mitsuhiro¹,Kondo Ryota²,Taniai Nobuhiko³,Ohashi Ryuji¹,Yoshida Hiroshi²,Naito Zenya¹

Affiliation:

1. Department of Integrated Diagnostic Pathology, Nippon Medical School, Tokyo 113‑8602, Japan

2. Department of Gastrointestinal and Hepato‑Biliary‑Pancreatic Surgery, Nippon Medical School, Tokyo 113‑8602, Japan

3. Department of Gastrointestinal and Hepato‑Biliary‑Pancreatic Surgery, Nippon Medical School Musashi Kosugi Hospital, Tokyo 211‑8533, Japan

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Roles of Rictor alterations in gastrointestinal tumors (Review);Oncology Reports;2024-01-04

2. Protein Disulfide Isomerase A3 (PDIA3): A Pharmacological Target in Glioblastoma?;International Journal of Molecular Sciences;2023-08-26

3. PDIA3 Expression Is Altered in the Limbic Brain Regions of Triple-Transgenic Mouse Model of Alzheimer’s Disease;International Journal of Molecular Sciences;2023-02-03

4. Protein Disulfide-Isomerase A3 Is a Robust Prognostic Biomarker for Cancers and Predicts the Immunotherapy Response Effectively;Frontiers in Immunology;2022-03-25

5. ERp57/PDIA3: new insight;Cellular & Molecular Biology Letters;2022-02-02